Novartis Sues Biogen, Others Over Gene Sequencing IP
Novartis Vaccines and Diagnostics Inc. has accused three biopharmaceutical companies including AstraZeneca PLC subsidiary MedImmune LLC of manufacturing treatments that infringe its diagnostic gene sequence technology....To view the full article, register now.
Already a subscriber? Click here to view full article